re: from glasgow icetrader
You can pour cold water on the take over option Respironics only has a cap of $US 2100 Million (35.7 M shares @ $60.00 each 229M in sales 80 M income).
PBI would probably get sold for around US $20 m
ResMed however as a cap of 2200 million ( 37M shares @ $61.00 each)maybe it could buy PBI as they have an extra 100 million in cap with assets of 624 million and liabilituies of 197 million and a revenue of 103 million with an eps of .52 (income 18 M ).
Obviously neither of the above companies could afford to buy PBI at such a low price of 20M as it would make them look overpriced .
So PBI will probably end up having to market its own product thats why the dream team have been brought in
PBI Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held